Alterations of bone metabolism of patients with primary and platinum-sensitive recurrent tuboovarian carcinoma induced by platinum-based chemotherapy with and without bevacizumab

被引：0
|
作者：
Kurbacher, C. M. [1 ]
Herz, S. [1 ]
Kurbacher, A. T. [1 ]
Rhau, W. [1 ]
Kurbacher, J. A. [1 ]
机构：
[1] Gynecol Ctr Bonn Friedenspl, Bonn, Germany
来源：
GYNECOLOGIC ONCOLOGY | 2019年 / 154卷
关键词：
D O I：
10.1016/j.ygyno.2019.04.178
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1247
引用
收藏
页码：75 / 75
页数：1
相关论文
共 50 条
  • [11] Thymic carcinoma: outcome of radiotherapy with or without platinum-based chemotherapy
    Chen, HHW
    Chen, FF
    Lai, WW
    Su, WC
    Wu, MH
    Leung, HWC
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 454 - 455
  • [12] Concerns with "maintenance chemotherapy" for patients with recurrent platinum-sensitive ovarian cancer - Reply
    Eltabbakh, GH
    Piver, MS
    GYNECOLOGIC ONCOLOGY, 1999, 73 (03) : 470 - 472
  • [13] ROLE OF SECONDARY CYTOREDUCTIVE SURGERY AND BEVACIZUMAB IN PLATINUM-SENSITIVE RECURRENT OVARIAN CLEAR CELL CARCINOMA
    Kim, Se Ik
    Kim, Sunyoung
    Kim, Ki Dong
    Park, Jeong-Yeol
    Lim, Myong Cheol
    Lee, Jeong-Won
    Kim, Jae-Weon
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A146 - A146
  • [14] Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer
    Aghajanian, Carol
    Goff, Barbara
    Nycum, Lawrence R.
    Wang, Yan V.
    Husain, Amreen
    Blank, Stephanie V.
    GYNECOLOGIC ONCOLOGY, 2015, 139 (01) : 10 - 16
  • [15] Platinum-based chemotherapy with or without thoracic radiation therapy in patients with unresectable thymic carcinoma
    Nakamura, Y
    Kunitoh, H
    Kubota, K
    Sekine, I
    Shinkai, T
    Tamura, T
    Kodama, T
    Sumi, M
    Kohno, S
    Saijo, N
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2000, 30 (09) : 385 - 388
  • [16] Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial
    Liu, Joyce F.
    Brady, Mark F.
    Matulonis, Ursula A.
    Miller, Austin
    Kohn, Elise C.
    Swisher, Elizabeth M.
    Cella, David
    Tew, William P.
    Cloven, Noelle G.
    Muller, Carolyn Y.
    Bender, David P.
    Moore, Richard G.
    Michelin, David P.
    Waggoner, Steven E.
    Geller, Melissa A.
    Fujiwara, Keiichi
    D'Andre, Stacy D.
    Carney, Michael
    Secord, Angeles Alvarez
    Moxley, Katherine M.
    Bookman, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (19) : 2138 - +
  • [17] RECHALLENGE WITH PLATINUM-BASED CHEMOTHERAPY AFTER TRABECTEDIN IN HEAVELY PRE-TREATED PATIENTS WITH PLATINUM-RESISTANT/REFRACTORY (PRR) AND PARTIALLY PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER (PPS-ROC)
    Casado, A.
    Callata Carhuapoma, H. R.
    Sanchiz, B.
    Manzano Fernandez, A.
    Sotelo Lezama, M. J.
    Cabezas-Camarero, S.
    Aguado De La Rosa, C.
    Coronado, P.
    Vidart Aragon, J. A.
    Diaz-Rubio Garcia, E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 468 - 469
  • [18] The predictive role of platinum-based chemotherapy combinations on the effectiveness of PARP-inhibitors as maintenance therapy in the platinum-sensitive recurrent ovarian cancer: an observational MITO study
    Agostinelli, Veronica
    Musacchio, Lucia
    Camarda, Floriana
    Pignata, Sandro
    Cecere, Sabrina Chiara
    Valabrega, Giorgio
    Tuninetti, Valentina
    Raspagliesi, Francesco
    Artioli, Grazia
    Perniola, Giorgia
    Cassani, Chiara
    Carmine, De Angelis
    Marchetti, Claudia
    Distefano, Mariagrazia
    Angioli, Roberto
    Cormio, Gennaro
    Mammoliti, Serafina
    Picardo, Elisa
    Scambia, Giovanni
    Lorusso, Domenica
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A339 - A340
  • [19] Study on the short-term efficacy and safety of bevacizumab combined with chemotherapy for platinum-sensitive recurrent ovarian cancer
    Li, Changhui
    Cheng, Wei
    Yu, Shaohui
    Xuan, Jing
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 : 195 - 196
  • [20] PLATINUM-BASED CHEMOTHERAPY FOR RECURRENT CNS TUMORS IN YOUNG-PATIENTS
    DOUEK, E
    KINGSTON, JE
    MALPAS, JS
    PLOWMAN, PN
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1991, 54 (08): : 722 - 725
12345